1.
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
by Molina, Jean-Michel, Dr, Prof
The Lancet (British edition), 2011, Vol.378 (9787), p.238-246

2.
The HIV care continuum in Latin America: challenges and opportunities
by Piñeirúa, Alicia, MD
The Lancet infectious diseases, 2015, Vol.15 (7), p.833-839

3.
Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?
by Mills, Edward J, Dr
The Lancet (British edition), 2008, Vol.371 (9613), p.685-688

4.
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine
by HAAS, David W
AIDS (London), 2000, Vol.14 (13), p.1973-1978

5.
Antiretroviral Resistance among HIV Type 1-Infected Women First Exposed to Antiretrovirals during Pregnancy : Plasma versus PBMCs
by SOTO-RAMIREZ, Luis E
AIDS research and human retroviruses, 2008, Vol.24 (6), p.797-804
